Severe acute respiratory syndrome coronavirus 2 pandemic capacity is derived from the unique structural features on its spike protein: fast viral surfing over the epithelium with flat N‐terminal domain, tight binding to ACE2 entry receptor, and furin protease utilization. In addition, the possible involvement of other components such as lipid rafts, CLRs, and neuropilin is, in combination, mediating the accelerated cell entry and other critical steps in its overwhelming contagious capacity and pandemy.
Therapeutic options for the highly pathogenic human severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) causing the current pandemic coronavirus disease (COVID-19)
are urgently needed. COVID-19 is associated with viral pneumonia and acute respiratory
distress syndrome causing significant morbidity and mortality. The proposed treatments
for COVID-19 have shown little or no effect in the clinic so far. Additionally,
bacterial and fungal pathogens contribute to the SARS-CoV-2-mediated pneumonia disease
complex. The antibiotic resistance in pneumonia treatment is increasing at an alarming
rate. Therefore, carbon-based nanomaterials (CBNs), such as fullerene, carbon dots,
graphene, and their derivatives constitute a promising alternative due to their
wide-spectrum antimicrobial activity, biocompatibility, biodegradability, and capacity
to induce tissue regeneration. Furthermore, the antimicrobial mode of action is mainly
physical (
e.g.
, membrane distortion), characterized by a low risk of
antimicrobial resistance. In this Review, we evaluated the literature on the antiviral
activity and broad-spectrum antimicrobial properties of CBNs. CBNs had antiviral
activity against 13 enveloped positive-sense single-stranded RNA viruses, including
SARS-CoV-2. CBNs with low or no toxicity to humans are promising therapeutics against
the COVID-19 pneumonia complex with other viruses, bacteria, and fungi, including those
that are multidrug-resistant.
Diabetes affects some functional properties of epidermis and dermis that may responsible for many cutaneous manifestations of diabetes. These results suggest that patients with diabetes mellitus tend to show a normal hydration state of the SC together with decreased sebaceous gland activity and impaired skin elasticity, without any impairment of the SC barrier function.
DHEA-S plays a key role in the pathogenesis of adult-onset acne. Measurement of circulating androgens, including DHEA-S, especially in patients presenting with adult-onset acne and hirsutism, is helpful, and patients with elevated levels can benefit from hormonal therapy.
A global emergency due to the COVID-19 pandemic demands various studies related to genes and genomes of the SARS-CoV2. Among other important proteins, the role of accessory proteins are of immense importance in replication, regulation of infections of the coronavirus in the hosts. The largest accessory protein in the SARS-CoV2 genome is ORF3a which modulates the host response to the virus infection and consequently it plays an important role in pathogenesis. In this study, an attempt is made to decipher the conservation of nucleotides, dimers, codons and amino acids in the ORF3a genes across thirty-two genomes of Indian patients. ORF3a gene possesses single and double point mutations in Indian SARS-CoV2 genomes suggesting the change of SARS-CoV2's virulence property in Indian patients. We find that the parental origin of the ORF3a gene over the genomes of SARS-CoV2 and Pangolin-CoV is same from the phylogenetic analysis based on conservation of nucleotides and so on. This study highlights the accumulation of mutation on ORF3a in Indian SARS-CoV2 genomes which may provide the designing therapeutic approach against SARS-CoV2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.